Insiders · SPRB

SPRB insider transactions

Spruce Biosciences Inc. (SPRB) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

SPRB insiders

Everyone who has filed a Form 3, 4, 5 or 144 at Spruce Biosciences Inc., latest first. Follow anyone to get their next filing.

• Adrian W QuartelChief Medical Officer, since July 2026
• Javier B. SzwarcbergChief Executive Officer, Director, since January 2022
• Daniel K SpiegelmanDirector
• Percival Barretto-KoDirector, since May 2023
• Camilla V SimpsonDirector-$232K
• Michael G GreyExecutive Chairman, Director
• Keli WalbertDirector, since December 2025
• Corwin Dale HooksChief Commercial Officer, since March 2026
• Douglas Kirk WaysInterim Chief Medical Officer, Director, since June 2021
• Samir M. GharibPresident and CFO
• Parkman Healthcare Partners LLC10% owner, since October 2025+$9,170-$9,840
• Tiba AynechiDirector
• Bali MuralidharDirector
• Ralph William Charlton IIIChief Medical Officer, since March 2022
• Novo Holdings A/S10% owner+$7M-$3.41M
• Niall O'DonnellDirector+$2M
• Moghrabi Dina ChayaDirector
• Subaweerage DiasOfficer
• Richard KingOfficer, Director

Recent Form 3, 4, and 5 filings for SPRB

• 102d
  SEC Form 4 filed by Chief Medical Officer Quartel Adrian W

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 102d
  SEC Form 3 filed by new insider Quartel Adrian W

  3 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 122d
  CHIEF EXECUTIVE OFFICER Szwarcberg Javier B. was granted 266 shares, increasing direct ownership by 1% to 19,270 units (SEC Form 4)

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 166d
  SEC Form 4 filed by Director Spiegelman Daniel K

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 166d
  SEC Form 4 filed by Director Simpson Camilla V

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 166d
  SEC Form 4 filed by Director Barretto-Ko Percival

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 166d
  SEC Form 4 filed by Executive Chairman Grey Michael G

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 166d
  SEC Form 4 filed by Director Walbert Keli

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 244d
  SEC Form 4 filed by Chief Commercial Officer Hooks Corwin Dale

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 244d
  SEC Form 3 filed by new insider Hooks Corwin Dale

  3 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 291d
  Interim Chief Medical Officer Ways Douglas Kirk converted options into 1,250 shares (SEC Form 4)

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 307d
  CHIEF EXECUTIVE OFFICER Szwarcberg Javier B. was granted 4,690 shares, increasing direct ownership by 33% to 19,004 units (SEC Form 4)

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 326d
  PRESIDENT AND CFO Gharib Samir M. converted options into 1,009 shares and covered exercise/tax liability with 362 shares, increasing direct ownership by 8% to 8,263 units (SEC Form 4)

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 326d
  CHIEF EXECUTIVE OFFICER Szwarcberg Javier B. converted options into 2,676 shares and covered exercise/tax liability with 1,360 shares, increasing direct ownership by 10% to 14,314 units (SEC Form 4)

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 328d
  SEC Form 4 filed by Director Spiegelman Daniel K

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 328d
  SEC Form 4 filed by Executive Chairman Grey Michael G

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 328d
  SEC Form 4 filed by PRESIDENT AND CFO Gharib Samir M.

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 328d
  SEC Form 4 filed by CHIEF EXECUTIVE OFFICER Szwarcberg Javier B.

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 328d
  SEC Form 4 filed by Director Simpson Camilla V

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 328d
  SEC Form 4 filed by Director Barretto-Ko Percival

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 328d
  SEC Form 4 filed by Director Walbert Keli

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 328d
  SEC Form 3 filed by new insider Walbert Keli

  3 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 331d
  PRESIDENT AND CFO Gharib Samir M. converted options into 2,414 shares and covered exercise/tax liability with 864 shares, increasing direct ownership by 26% to 7,616 units (SEC Form 4)

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 331d
  CHIEF EXECUTIVE OFFICER Szwarcberg Javier B. converted options into 6,146 shares and covered exercise/tax liability with 2,622 shares, increasing direct ownership by 37% to 12,998 units (SEC Form 4)

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 382d
  PRESIDENT AND CFO Gharib Samir M. converted options into 2,053 shares and covered exercise/tax liability with 661 shares, increasing direct ownership by 30% to 6,066 units (SEC Form 4)

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 382d
  CHIEF EXECUTIVE OFFICER Szwarcberg Javier B. converted options into 4,784 shares and covered exercise/tax liability with 1,539 shares, increasing direct ownership by 52% to 9,474 units (SEC Form 4)

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 389d
  Large owner Parkman Healthcare Partners Llc bought $4,585 worth of shares (256 units at $17.91) and sold $4,920 worth of shares (257 units at $19.14) (SEC Form 4)

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 389d
  New insider Parkman Healthcare Partners Llc claimed ownership of 1,051 shares (SEC Form 3)

  3 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 396d
  Large owner Parkman Healthcare Partners Llc bought $4,585 worth of shares (256 units at $17.91) and sold $4,920 worth of shares (257 units at $19.14) (SEC Form 4)

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 396d
  New insider Parkman Healthcare Partners Llc claimed ownership of 1,051 shares (SEC Form 3)

  3 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 472d
  SEC Form 4 filed by Director Spiegelman Daniel K

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 472d
  SEC Form 4 filed by Director Simpson Camilla V

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 472d
  SEC Form 4 filed by Executive Chairman Grey Michael G

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 472d
  SEC Form 4 filed by Director Barretto-Ko Percival

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 472d
  SEC Form 4 filed by Director Aynechi Tiba

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 472d
  SEC Form 4 filed by Interim Chief Medical Officer Ways Kirk

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 472d
  SEC Form 4 filed by Director Muralidhar Bali

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 688d
  CHIEF MEDICAL OFFICER Charlton Ralph William Iii converted options into 164,750 shares and covered exercise/tax liability with 58,784 shares, increasing direct ownership by 191% to 161,339 units (SEC Form 4)

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 688d
  PRESIDENT AND CFO Gharib Samir M. converted options into 229,750 shares and covered exercise/tax liability with 81,976 shares, increasing direct ownership by 73% to 350,550 units (SEC Form 4)

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 688d
  CHIEF EXECUTIVE OFFICER Szwarcberg Javier B. converted options into 559,500 shares and covered exercise/tax liability with 199,630 shares, increasing direct ownership by 335% to 467,191 units (SEC Form 4)

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 898d
  SEC Form 4 filed by Ways Kirk

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 898d
  SEC Form 4 filed by Spiegelman Daniel K

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 898d
  SEC Form 4 filed by Simpson Camilla V

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 898d
  SEC Form 4 filed by Muralidhar Bali

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 898d
  SEC Form 4 filed by Grey Michael G

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 898d
  SEC Form 4 filed by Barretto-Ko Percival

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 898d
  SEC Form 4 filed by Aynechi Tiba

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 958d
  Novo Holdings A/S sold $350,951 worth of shares (465,021 units at $0.75), decreasing direct ownership by 15% to 2,550,000 units (SEC Form 4)

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 963d
  Novo Holdings A/S sold $1,358,804 worth of shares (1,794,999 units at $0.76), decreasing direct ownership by 37% to 3,015,021 units (SEC Form 4)

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 965d
  Novo Holdings A/S sold $1,698,902 worth of shares (1,912,316 units at $0.89), decreasing direct ownership by 28% to 4,810,020 units (SEC Form 4)

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 965d
  SEC Form 4 filed by Charlton Ralph William Iii

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 965d
  SEC Form 4 filed by Gharib Samir M.

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 965d
  SEC Form 4 filed by Szwarcberg Javier B.

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 1040d
  Charlton Ralph William Iii was granted 9,361 shares, increasing direct ownership by 20% to 55,373 units (SEC Form 4)

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 1040d
  Gharib Samir M. was granted 11,255 shares, increasing direct ownership by 6% to 202,776 units (SEC Form 4)

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 1056d
  Charlton Ralph William Iii converted options into 31,750 shares and covered exercise/tax liability with 10,980 shares, increasing direct ownership by 82% to 46,012 units (SEC Form 4)

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 1056d
  Gharib Samir M. converted options into 112,250 shares and covered exercise/tax liability with 36,095 shares, increasing direct ownership by 66% to 191,521 units (SEC Form 4)

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 1056d
  Szwarcberg Javier B. converted options into 111,000 shares and covered exercise/tax liability with 38,384 shares, increasing direct ownership by 209% to 107,321 units (SEC Form 4)

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 1076d
  SEC Form 4 filed by Szwarcberg Javier B.

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)
• 1091d
  SEC Form 4 filed by Gharib Samir M.

  4 - SPRUCE BIOSCIENCES, INC. (0001683553) (Issuer)